GENETIC REASSORTMENT OF ROTAVIRUSES FOR PRODUCTION OF VACCINES AND VACCINE PRECURSORS Read more about GENETIC REASSORTMENT OF ROTAVIRUSES FOR PRODUCTION OF VACCINES AND VACCINE PRECURSORS Austria84401357.3Filed on 1984-06-27
GENETIC REASSORTMENT OF ROTAVIRUSES FOR PRODUCTION OF VACCINES AND VACCINE PRECURSORS Read more about GENETIC REASSORTMENT OF ROTAVIRUSES FOR PRODUCTION OF VACCINES AND VACCINE PRECURSORS Australia31505/84Filed on 1984-06-27
Process for Using Poxviruses as Vectors for Expression of Foreign Genes Read more about Process for Using Poxviruses as Vectors for Expression of Foreign Genes Switzerland83111976.3Filed on 1983-11-28
Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases Read more about Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases Japan2000-583564Filed on 1999-11-23
Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases Read more about Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases European Patent99965880.0Filed on 1999-11-23
Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases Read more about Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases Australia21558/00Filed on 1999-11-23
SIMIAN-HUMAN HAV HAVING A CHIMERIC 2C PROTEIN CHIMERIC 2C PROTEIN Read more about SIMIAN-HUMAN HAV HAVING A CHIMERIC 2C PROTEIN CHIMERIC 2C PROTEIN European Patent97923424.2Filed on 1997-04-18
IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY Read more about IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY United Kingdom94920673.4Filed on 1994-05-19
IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY Read more about IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY Portugal94920673.4Filed on 1994-05-19
IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY Read more about IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY Luxembourg94920673.4Filed on 1994-05-19